The Impact of Marijuana Pharmaceuticals

John Robert Alfino


September 15, 2013

FDA will soon approve Sativex, the first marijuana-based pharmaceutical. Sativex is a tipping point in the marijuana law and the politics of strict prohibition. The reclassification of marijuana under the Controlled Substances Act is in the financial interests of the American pharmaceutical industry. The availability of marijuana-based, or synthetic cannabinoid-based, pharmaceuticals will change the politics of marijuana prohibition.

Number of Pages in PDF File: 6

Keywords: marijuana, Sativex, cannabinoid

Open PDF in Browser Download This Paper

Date posted: September 16, 2013  

Suggested Citation

Alfino, John Robert, The Impact of Marijuana Pharmaceuticals (September 15, 2013). Available at SSRN: https://ssrn.com/abstract=2326245 or http://dx.doi.org/10.2139/ssrn.2326245

Contact Information

John Robert Alfino (Contact Author)
Independent ( email )
No Address Available
Feedback to SSRN

Paper statistics
Abstract Views: 174
Downloads: 35